Stay updated on CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedA new revision entry v3.4.3 was added. The previous entry v3.4.2 was removed from the study record history.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.4.2 was added and earlier notices about funding and operating status were removed. These are administrative site updates that do not affect trial data or core page content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check38 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operations. Updated the site version to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.8%

- Check45 days agoChange DetectedThe history view received minor UI updates, including a Show glossary option, color-coded highlight explanations, and an updated revision tag (v3.4.0 replacing v3.3.4). These changes do not affect core trial data or content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check81 days agoChange DetectedRevision: v3.3.3 has been added to the study history, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check102 days agoChange DetectedA new revision (v3.3.2) was added, replacing the previous v3.3.1, which appears to be a minor update to the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page.